News
Important Only
US striking Iran-aligned militia in Iraq, top US general says
WASHINGTON, March 19 (Reuters) - The United States has carried out strikes against Iran-aligned militia groups in Iraq, the top U.S. general said on Thursday."AH-64s have been striking against Iranian-aligned militia groups to make sure that we suppress any threat in Iraq against U.S. forces or ...Reuters
23 minutes ago
US FDA approves GSK's drug for liver disease-related itching
March 19 (Reuters) - The U.S. Food and Drug Administration approved GSK's GSK.L drug for severe relentless itching caused by a type of liver disease, the company said on Thursday, making it the first treatment greenlit for the condition.The drug, branded Lynavoy, was approved for patients with p...Reuters
25 minutes ago
Ryanair CEO expects Boeing MAX 10 deliveries to run on time
BRUSSELS, March 19 (Reuters) - European budget carrier Ryanair RYA.I expects Boeing BA.N to get certification of its MAX 10 aircraft in the third quarter of the year, with deliveries set to be on time early next year, CEO Michael O'Leary told Reuters at an event in Brussels.Reuters
29 minutes ago
Paris appeals court rejects France's attempt to suspend Shein's marketplace
Paris appeals court upholds December court decisionFrance tried to suspend Shein after childlike sex dolls found on platformShein says it has banned sex dolls worldwide, taken steps to reinforce controlsBy Helen Reid PARIS, March 19 (Reuters) - France's bid to suspend Chinese online retailer ...Reuters
29 minutes ago
US objectives in Iran have not changed, Hegseth says
WASHINGTON, March 19 (Reuters) - U.S. Defense Secretary Pete Hegseth said on Thursday that the United States' objectives in the war against Iran have not changed since strikes started on February 28.Hegseth told reporters that the objectives remained to destroy Iran's missile launchers, its ...Reuters
31 minutes ago
Lilly's next-gen drug shows significant blood sugar, weight reduction in diabetes trial
By Christy Santhosh March 19 (Reuters) - Eli Lilly LLY.N's next-generation obesity drug showed a significant reduction in blood sugar levels and weight in a late-stage trial, the company said on Thursday, as it looks to widen its lead in the heavily contested market for GLP-1 drugs.Drug devel...Reuters
31 minutes ago
ADVISORY-Alert wrongly tagged to Amazon withdrawn
An alert on Hammacher Schlemmer’s acquisition by a former Woot leadership team was incorrectly tagged to Amazon AMZN.O and has been withdrawn. There will be no substitute alert.STORY_NUMBER: nTUA9KYNRXSTORY_DATE: 19/03/2026STORY_TIME: 12:00:04 GMTReuters
34 minutes ago
3M expands safety portfolio with $1.95 billion Madison Fire deal
March 19 (Reuters) - 3M MMM.N will spin off its Scott Safety business and team up with Bain Capital to buy Madison Fire & Rescue for $1.95 billion, combining the two to create a fire and safety joint venture that will expand the industrial giant's safety portfolio.3M will own 50.1% of the ne...Reuters
35 minutes ago
Lexinfintech Holdings Going Forward, Co. Believes That Market Will Continue To Consolidate Toward Leading, Compliant Platforms
March 19 (Reuters) - Lexinfintech Holdings Ltd LX.O:LEXINFINTECH HOLDINGS: GOING FORWARD, CO. BELIEVES THAT MARKET WILL CONTINUE TO CONSOLIDATE TOWARD LEADING, COMPLIANT PLATFORMSLEXINFINTECH HOLDINGS LTD: EXPECTS TOTAL LOAN ORIGINATION FOR Q1 2026 TO REMAIN FLATSource text: [ID:n0001193125-26-11511...Reuters
35 minutes ago
Hillman Outlines Blueprint For Strategic Growth Plans And Long-Term Financial Objectives At Inaugural Investor Day
March 19 (Reuters) - Hillman Solutions Corp HLMN.O:HILLMAN OUTLINES BLUEPRINT FOR STRATEGIC GROWTH PLANS AND LONG-TERM FINANCIAL OBJECTIVES AT INAUGURAL INVESTOR DAYHILLMAN SOLUTIONS CORP - TARGETS $2.5 BILLION IN NET SALES BY 2030HILLMAN SOLUTIONS CORP - AFFIRMS 2026 GUIDANCE: $1.6-$1.7 BILLION NET...Reuters
35 minutes ago
Aebi Schmidt Group Closed Q4 2025 With Adjusted EBITDA Growing By 31% And Order Intake Increasing By 46% Versus Q4 2024, Well Positioned To Accelerate Order Conversion And Grow Profitability In 2026
March 19 (Reuters) - Aebi Schmidt Holding AG AEBI.O:AEBI SCHMIDT GROUP CLOSED Q4 2025 WITH ADJUSTED EBITDA GROWING BY 31% AND ORDER INTAKE INCREASING BY 46% VERSUS Q4 2024, WELL POSITIONED TO ACCELERATE ORDER CONVERSION AND GROW PROFITABILITY IN 2026AEBI SCHMIDT HOLDING AG - 2026 GUIDANCE: NET SALES...Reuters
36 minutes ago
Mirasol Signs Loi For The Sale Of The Rubi Copper Project For Us$4 Million Plus 2% Nsr Royalty
March 19 (Reuters) - Mirasol Resources Ltd MRZ.V:MIRASOL SIGNS LOI FOR THE SALE OF THE RUBI COPPER PROJECT FOR US$4 MILLION PLUS 2% NSR ROYALTYMIRASOL RESOURCES LTD - RETAINS 2% NSR ROYALTY; SAN LORENZO MAY BUY BACK 1% FOR $4 MILLIONReuters
36 minutes ago
Chicago Atlantic BDC, Inc. Reports Fourth Quarter And Full Year 2025 Financial Results
March 19 (Reuters) - Chicago Atlantic BDC Inc LIEN.O:CHICAGO ATLANTIC BDC, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTSCHICAGO ATLANTIC BDC INC - Q4 2025 TOTAL GROSS INVESTMENT INCOME WAS $14.2 MILLIONCHICAGO ATLANTIC BDC INC - Q4 2025 NET INVESTMENT INCOME WAS $8.3 MILLION, OR $...Reuters
36 minutes ago
Vr Receives Noi Drill Permit For Its New Boston Moly-Tungsten-Copper-Silver Porphyry Project In Nevada
March 19 (Reuters) - VR Resources Ltd VRR.V:VR RECEIVES NOI DRILL PERMIT FOR ITS NEW BOSTON MOLY-TUNGSTEN-COPPER-SILVER PORPHYRY PROJECT IN NEVADAVR RESOURCES LTD - PERMIT INCLUDES EIGHT DRILL SITES IN JEEP MINE AREA OVER 3-4 KM STRIKEReuters
36 minutes ago
Israel's Chemomab Q4 net loss narrows on lower R&D spend
OverviewIsrael biotech developer's Q4 and full-year operating expenses declined Net loss for Q4 and full year narrowed compared to 2024Company achieved FDA alignment on Phase 3 trial design for nebokitug in PSCOutlookChemomab expects cash runway to last through end of Q1 2027Chemomab evaluating ...Reuters
37 minutes ago
AC Immune Presents First In Vivo Images Of Brain Tdp-43 Pathology From Phase 1 Trial Of Pet Tracer Aci-19626, At Ad/Pdtm 2026
March 19 (Reuters) - AC Immune SA ACIU.O:AC IMMUNE PRESENTS FIRST IN VIVO IMAGES OF BRAIN TDP-43 PATHOLOGY FROM PHASE 1 TRIAL OF PET TRACER ACI-19626, AT AD/PDTM 2026Reuters
38 minutes ago
